GLP-1 medications are contraindicated in severe gastroparesis and should be used cautiously in patients with gastrointestinal disease
Overexpressed Pro1 mediated accumulation of -glutamyl phosphate which was partially diverted toward GSH production, while heterologous ProB (optimized according to codon usage of S
& Offermanns, S
Disease stage and remaining tissue considerations Early disease with substantial viable tissue: Maximum benefit from protective mechanisms
Gut 62:17241733 Koehler JA, Baggio LL, Yusta B, Longuet C, Rowland KJ, Cao X, Holland D, Brubaker PL, Drucker DJ (2015) GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7
Preclinical studies have investigated its ability to stimulate melanin production, contributing to skin pigmentation responses in laboratory models, alongside potential effects on energy balance and libido regulation